Transformative Breast Cancer Consortium Award
Funds large, multidisciplinary consortia to collaboratively tackle major breast cancer research challenges and accelerate progress toward ending breast cancer.
Funder: Military Health System Research Program
Due Dates (Anticipated): June 2026: Preproposal deadline (projected) | September 2026: Full application deadline (projected, by invitation)
Funding Amounts: Up to $35 million total costs over 4 years per consortium.
Summary: Supports large, multidisciplinary consortia to tackle major breast cancer challenges through integrated research teams, aiming to accelerate progress toward ending breast cancer.
Key Information: Preproposal required; full applications by invitation only.
Description
This opportunity supports the formation of highly integrated, multidisciplinary, and multi-institutional research consortia to address transformative challenges in breast cancer research. The mechanism is designed for teams of leading scientists, clinicians, and consumer advocates to collaboratively address a central hypothesis that cannot be accomplished by a single investigator or group. The consortium must comprise four to five project teams, each contributing distinct but synergistic projects under a unified goal. The award encourages innovative, large-scale collaborations and may include clinical trials up to phase 1, though a clinical trial is not required. Each project team must include at least one consumer advocate. The overarching aim is to accelerate progress toward ending breast cancer for service members, veterans, and the general public.
